Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 30, 2024

SELL
N/A
-18,000 Closed
0 $0
Q3 2021

Aug 30, 2024

SELL
N/A
-150 Reduced 0.83%
18,000 $312 Million
Q2 2021

Aug 30, 2024

BUY
N/A
18,150 New
18,150 $175 Million
Q1 2021

Aug 30, 2024

SELL
N/A
-216 Reduced 1.18%
18,150 $193 Million
Q4 2020

Aug 30, 2024

BUY
N/A
1,000 Added 5.76%
18,366 $267 Million
Q2 2020

Aug 30, 2024

BUY
N/A
300 Added 1.76%
17,366 $140 Million
Q1 2020

Aug 30, 2024

SELL
N/A
-13,000 Reduced 43.24%
17,066 $66.5 Million
Q4 2019

Aug 30, 2024

BUY
N/A
30,000 Added 45454.55%
30,066 $29.7 Million
Q4 2018

Aug 30, 2024

BUY
N/A
66 New
66 $113,000
Q4 2017

Aug 30, 2024

SELL
N/A
-2,666 Reduced 97.58%
66 $456,000
Q2 2017

Aug 30, 2024

BUY
N/A
66 Added 2.48%
2,732 $11.8 Million
Q1 2017

Aug 30, 2024

BUY
N/A
2,666
2,666 $16.1 Million

About Trillium Therapeutics Inc.


  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.